Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain

NCT02362672 is registered in ClinicalTrials.gov with Nektar Therapeutics as lead sponsor.

NCT NCT02362672
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02362672 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3 Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naive Subjects With Moderate to Severe Chronic Low Back Pain
Lead sponsor
Nektar Therapeutics
Phase
Phase 3
Overall status
Completed
Start date
March 11, 2015
Completion date
February 28, 2017
Enrollment
1,189 (actual)
Sites
54

Conditions

As the registry lists them; a condition with its own page is linked.

chronic pain, low back pain